Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 16, 2025

CRISPR/Cas-based detection strategies for tumor biomarker detection.

View Full Paper
Ask AI
Bookmark
Share

Authors

KYKe YangTWTong WangQZQuanjing Zhu

Discussion

Loading...

Member takes

Overview

Review reveals CRISPR/Cas improves sensitivity and specificity in tumor biomarker detection, indicating potential for multiplex assessment.

Key Points

  • CRISPR/Cas-based detection strategies demonstrate high sensitivity and specificity for tumor biomarkers, utilizing novel methodologies.
  • Multiplex detection capabilities of CRISPR/Cas systems allow simultaneous analysis of multiple tumor biomarkers, enhancing diagnostic efficiency.
  • These systems integrate well with isothermal amplification techniques, making them versatile for various detection applications.
  • The review discusses current challenges and future prospects of CRISPR/Cas-based approaches in clinical settings, signifying their importance in tumor detection.

Cite This Study

Yang et al. (2025) studied this question.

synapsesocial.com/papers/68c93fe601120bef803bb08chttps://doi.org/10.1039/d5ay01150g
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Exponential Amplification-Induced Activation of CRISPR/Cas9 for Sensitive Detection of Exosomal miRNA2024 · 11 citations
  2. 2Nucleic Acid Detection of Plant Genes Using CRISPR-Cas132019 · 127 citations
  3. 3RNA-Activated CRISPR/Cas12a Nanorobots Operating in Living Cells2024 · 96 citations
  4. 4The CRISPR–Cas toolbox for analytical and diagnostic assay development2021 · 222 citations
  5. 5C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector2016 · 2,463 citations